Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders
Psychobiotics are a group of probiotics that affect the central nervous system (CNS) related functions and behaviors mediated by the gut-brain-axis (GBA) via immune, humoral, neural, and metabolic pathways to improve not only the gastrointestinal (GI) function but also the antidepressant and anxioly...
Gespeichert in:
| Veröffentlicht in: | Journal of food and drug analysis 2019-07, Vol.27 (3), p.632-648 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 648 |
|---|---|
| container_issue | 3 |
| container_start_page | 632 |
| container_title | Journal of food and drug analysis |
| container_volume | 27 |
| creator | Cheng, Li-Hao Liu, Yen-Wenn Wu, Chien-Chen Wang, Sabrina Tsai, Ying-Chieh |
| description | Psychobiotics are a group of probiotics that affect the central nervous system (CNS) related functions and behaviors mediated by the gut-brain-axis (GBA) via immune, humoral, neural, and metabolic pathways to improve not only the gastrointestinal (GI) function but also the antidepressant and anxiolytic capacity. As a novel class of probiotics, the application of psychobiotics has led researchers to focus on a new area in neuroscience. In the past five years, some psychobiotics strains were reported to inhibit inflammation and decreased cortisol levels, resulting in an amelioration of the symptoms of anxiety and depression. Psychobiotics are efficacious in improving neurodegenerative and neurodevelopmental disorders, including autism spectrum disorder (ASD), Parkinson's disease (PD) and Alzheimer's disease (AD). Use of psychobiotics can improve GI function, ASD symptoms, motor functions of patients with PD and cognition in patients with AD. However, the evidence for the effects of psychobiotics on mental and neurological conditions/disorders remains limited. Further studies of psychobiotics are needed in order to determine into their effectiveness and mechanism as treatments for various psychiatric disorders in the future.
[Display omitted]
•A brief review of the effects of psychobiotics on human mental, neurodegenerative and neurodevelopmental disorders.•Clinical studies of the effects psychobiotics on autism spectrum disorder are summarized.•Psychobiotic supplements show promise as an alternative therapy for human diseases. |
| doi_str_mv | 10.1016/j.jfda.2019.01.002 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9307042</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1021949819300158</els_id><sourcerecordid>2258096347</sourcerecordid><originalsourceid>FETCH-LOGICAL-c532t-674851e86b7a4c06da753c9baca45b30c324dc90563003e525754758a23a298c3</originalsourceid><addsrcrecordid>eNp9kd1rFDEUxYModq3-Az7IgC99cMabz5mACFL8goIi-hwyyd1uhtnJmsws9L9vlt0W7UOfLuT-zuHcHEJeU2goUPV-aIa1tw0DqhugDQB7QlaMMVErRcVTsqLAaK2F7s7Ii5wHACW5Zs_JGaecCdbBivz6mW_cJvYhzsHlKkzVFqfZjtUG7Thv3lUTLil6vMYJk53DHis7-bvXPY5xdxL4kGPymPJL8mxtx4yvTvOc_Pny-fflt_rqx9fvl5-uaic5m2vVik5S7FTfWuFAedtK7nRvnRWy5-BKRO80SMUBOEomWyla2VnGLdOd4-fk49F3t_Rb9K7ESHY0uxS2Nt2YaIP5fzOFjbmOe6M5tCBYMbg4GaT4d8E8m23IDsfRThiXbBgXAFJwLgr69gE6xCVN5TzDmOxAKy7aQrEj5VLMOeH6PgwFc6jMDOZQmTlUZoCaUlkRvfn3jHvJXUcF-HAEsHzmPmAy2QWcHPqQ0M3Gx_CY_y1UoKhC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2258096347</pqid></control><display><type>article</type><title>Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>PubMed Central Open Access</source><creator>Cheng, Li-Hao ; Liu, Yen-Wenn ; Wu, Chien-Chen ; Wang, Sabrina ; Tsai, Ying-Chieh</creator><creatorcontrib>Cheng, Li-Hao ; Liu, Yen-Wenn ; Wu, Chien-Chen ; Wang, Sabrina ; Tsai, Ying-Chieh</creatorcontrib><description>Psychobiotics are a group of probiotics that affect the central nervous system (CNS) related functions and behaviors mediated by the gut-brain-axis (GBA) via immune, humoral, neural, and metabolic pathways to improve not only the gastrointestinal (GI) function but also the antidepressant and anxiolytic capacity. As a novel class of probiotics, the application of psychobiotics has led researchers to focus on a new area in neuroscience. In the past five years, some psychobiotics strains were reported to inhibit inflammation and decreased cortisol levels, resulting in an amelioration of the symptoms of anxiety and depression. Psychobiotics are efficacious in improving neurodegenerative and neurodevelopmental disorders, including autism spectrum disorder (ASD), Parkinson's disease (PD) and Alzheimer's disease (AD). Use of psychobiotics can improve GI function, ASD symptoms, motor functions of patients with PD and cognition in patients with AD. However, the evidence for the effects of psychobiotics on mental and neurological conditions/disorders remains limited. Further studies of psychobiotics are needed in order to determine into their effectiveness and mechanism as treatments for various psychiatric disorders in the future.
[Display omitted]
•A brief review of the effects of psychobiotics on human mental, neurodegenerative and neurodevelopmental disorders.•Clinical studies of the effects psychobiotics on autism spectrum disorder are summarized.•Psychobiotic supplements show promise as an alternative therapy for human diseases.</description><identifier>ISSN: 1021-9498</identifier><identifier>ISSN: 2224-6614</identifier><identifier>EISSN: 2224-6614</identifier><identifier>DOI: 10.1016/j.jfda.2019.01.002</identifier><identifier>PMID: 31324280</identifier><language>eng</language><publisher>China (Republic : 1949- ): Elsevier Taiwan LLC</publisher><subject>Alzheimer's disease ; Antidepressants ; Anxiety ; Attention deficit hyperactivity disorder ; Autism ; Bifidobacterium ; Brain ; Brain-derived neurotrophic factor ; Central nervous system ; Cognition ; Disorders ; Human motion ; Humans ; Lactobacillus ; Mental depression ; Mental disorders ; Mental Health ; Metabolic pathways ; Movement disorders ; Nervous system ; Neurodegenerative diseases ; Neurodevelopmental disorders ; Neurodevelopmental Disorders - psychology ; Neurodevelopmental Disorders - therapy ; Neurological diseases ; Parkinson's disease ; Probiotics ; Psychiatric disorders ; Psychobiotics ; Review ; Signs and symptoms ; Studies ; Yogurt</subject><ispartof>Journal of food and drug analysis, 2019-07, Vol.27 (3), p.632-648</ispartof><rights>2019</rights><rights>Copyright © 2019. Published by Elsevier Taiwan LLC.</rights><rights>Copyright Elsevier Limited Jul 2019</rights><rights>2019 Taiwan Food and Drug Administration 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c532t-674851e86b7a4c06da753c9baca45b30c324dc90563003e525754758a23a298c3</citedby><cites>FETCH-LOGICAL-c532t-674851e86b7a4c06da753c9baca45b30c324dc90563003e525754758a23a298c3</cites><orcidid>0000-0002-4390-4742</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307042/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307042/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31324280$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cheng, Li-Hao</creatorcontrib><creatorcontrib>Liu, Yen-Wenn</creatorcontrib><creatorcontrib>Wu, Chien-Chen</creatorcontrib><creatorcontrib>Wang, Sabrina</creatorcontrib><creatorcontrib>Tsai, Ying-Chieh</creatorcontrib><title>Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders</title><title>Journal of food and drug analysis</title><addtitle>J Food Drug Anal</addtitle><description>Psychobiotics are a group of probiotics that affect the central nervous system (CNS) related functions and behaviors mediated by the gut-brain-axis (GBA) via immune, humoral, neural, and metabolic pathways to improve not only the gastrointestinal (GI) function but also the antidepressant and anxiolytic capacity. As a novel class of probiotics, the application of psychobiotics has led researchers to focus on a new area in neuroscience. In the past five years, some psychobiotics strains were reported to inhibit inflammation and decreased cortisol levels, resulting in an amelioration of the symptoms of anxiety and depression. Psychobiotics are efficacious in improving neurodegenerative and neurodevelopmental disorders, including autism spectrum disorder (ASD), Parkinson's disease (PD) and Alzheimer's disease (AD). Use of psychobiotics can improve GI function, ASD symptoms, motor functions of patients with PD and cognition in patients with AD. However, the evidence for the effects of psychobiotics on mental and neurological conditions/disorders remains limited. Further studies of psychobiotics are needed in order to determine into their effectiveness and mechanism as treatments for various psychiatric disorders in the future.
[Display omitted]
•A brief review of the effects of psychobiotics on human mental, neurodegenerative and neurodevelopmental disorders.•Clinical studies of the effects psychobiotics on autism spectrum disorder are summarized.•Psychobiotic supplements show promise as an alternative therapy for human diseases.</description><subject>Alzheimer's disease</subject><subject>Antidepressants</subject><subject>Anxiety</subject><subject>Attention deficit hyperactivity disorder</subject><subject>Autism</subject><subject>Bifidobacterium</subject><subject>Brain</subject><subject>Brain-derived neurotrophic factor</subject><subject>Central nervous system</subject><subject>Cognition</subject><subject>Disorders</subject><subject>Human motion</subject><subject>Humans</subject><subject>Lactobacillus</subject><subject>Mental depression</subject><subject>Mental disorders</subject><subject>Mental Health</subject><subject>Metabolic pathways</subject><subject>Movement disorders</subject><subject>Nervous system</subject><subject>Neurodegenerative diseases</subject><subject>Neurodevelopmental disorders</subject><subject>Neurodevelopmental Disorders - psychology</subject><subject>Neurodevelopmental Disorders - therapy</subject><subject>Neurological diseases</subject><subject>Parkinson's disease</subject><subject>Probiotics</subject><subject>Psychiatric disorders</subject><subject>Psychobiotics</subject><subject>Review</subject><subject>Signs and symptoms</subject><subject>Studies</subject><subject>Yogurt</subject><issn>1021-9498</issn><issn>2224-6614</issn><issn>2224-6614</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kd1rFDEUxYModq3-Az7IgC99cMabz5mACFL8goIi-hwyyd1uhtnJmsws9L9vlt0W7UOfLuT-zuHcHEJeU2goUPV-aIa1tw0DqhugDQB7QlaMMVErRcVTsqLAaK2F7s7Ii5wHACW5Zs_JGaecCdbBivz6mW_cJvYhzsHlKkzVFqfZjtUG7Thv3lUTLil6vMYJk53DHis7-bvXPY5xdxL4kGPymPJL8mxtx4yvTvOc_Pny-fflt_rqx9fvl5-uaic5m2vVik5S7FTfWuFAedtK7nRvnRWy5-BKRO80SMUBOEomWyla2VnGLdOd4-fk49F3t_Rb9K7ESHY0uxS2Nt2YaIP5fzOFjbmOe6M5tCBYMbg4GaT4d8E8m23IDsfRThiXbBgXAFJwLgr69gE6xCVN5TzDmOxAKy7aQrEj5VLMOeH6PgwFc6jMDOZQmTlUZoCaUlkRvfn3jHvJXUcF-HAEsHzmPmAy2QWcHPqQ0M3Gx_CY_y1UoKhC</recordid><startdate>20190701</startdate><enddate>20190701</enddate><creator>Cheng, Li-Hao</creator><creator>Liu, Yen-Wenn</creator><creator>Wu, Chien-Chen</creator><creator>Wang, Sabrina</creator><creator>Tsai, Ying-Chieh</creator><general>Elsevier Taiwan LLC</general><general>Food and Drug Administration</general><general>Taiwan Food and Drug Administration</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RQ</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>L6V</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4390-4742</orcidid></search><sort><creationdate>20190701</creationdate><title>Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders</title><author>Cheng, Li-Hao ; Liu, Yen-Wenn ; Wu, Chien-Chen ; Wang, Sabrina ; Tsai, Ying-Chieh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c532t-674851e86b7a4c06da753c9baca45b30c324dc90563003e525754758a23a298c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Alzheimer's disease</topic><topic>Antidepressants</topic><topic>Anxiety</topic><topic>Attention deficit hyperactivity disorder</topic><topic>Autism</topic><topic>Bifidobacterium</topic><topic>Brain</topic><topic>Brain-derived neurotrophic factor</topic><topic>Central nervous system</topic><topic>Cognition</topic><topic>Disorders</topic><topic>Human motion</topic><topic>Humans</topic><topic>Lactobacillus</topic><topic>Mental depression</topic><topic>Mental disorders</topic><topic>Mental Health</topic><topic>Metabolic pathways</topic><topic>Movement disorders</topic><topic>Nervous system</topic><topic>Neurodegenerative diseases</topic><topic>Neurodevelopmental disorders</topic><topic>Neurodevelopmental Disorders - psychology</topic><topic>Neurodevelopmental Disorders - therapy</topic><topic>Neurological diseases</topic><topic>Parkinson's disease</topic><topic>Probiotics</topic><topic>Psychiatric disorders</topic><topic>Psychobiotics</topic><topic>Review</topic><topic>Signs and symptoms</topic><topic>Studies</topic><topic>Yogurt</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cheng, Li-Hao</creatorcontrib><creatorcontrib>Liu, Yen-Wenn</creatorcontrib><creatorcontrib>Wu, Chien-Chen</creatorcontrib><creatorcontrib>Wang, Sabrina</creatorcontrib><creatorcontrib>Tsai, Ying-Chieh</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Career & Technical Education Database</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Engineering Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Engineering Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of food and drug analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cheng, Li-Hao</au><au>Liu, Yen-Wenn</au><au>Wu, Chien-Chen</au><au>Wang, Sabrina</au><au>Tsai, Ying-Chieh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders</atitle><jtitle>Journal of food and drug analysis</jtitle><addtitle>J Food Drug Anal</addtitle><date>2019-07-01</date><risdate>2019</risdate><volume>27</volume><issue>3</issue><spage>632</spage><epage>648</epage><pages>632-648</pages><issn>1021-9498</issn><issn>2224-6614</issn><eissn>2224-6614</eissn><abstract>Psychobiotics are a group of probiotics that affect the central nervous system (CNS) related functions and behaviors mediated by the gut-brain-axis (GBA) via immune, humoral, neural, and metabolic pathways to improve not only the gastrointestinal (GI) function but also the antidepressant and anxiolytic capacity. As a novel class of probiotics, the application of psychobiotics has led researchers to focus on a new area in neuroscience. In the past five years, some psychobiotics strains were reported to inhibit inflammation and decreased cortisol levels, resulting in an amelioration of the symptoms of anxiety and depression. Psychobiotics are efficacious in improving neurodegenerative and neurodevelopmental disorders, including autism spectrum disorder (ASD), Parkinson's disease (PD) and Alzheimer's disease (AD). Use of psychobiotics can improve GI function, ASD symptoms, motor functions of patients with PD and cognition in patients with AD. However, the evidence for the effects of psychobiotics on mental and neurological conditions/disorders remains limited. Further studies of psychobiotics are needed in order to determine into their effectiveness and mechanism as treatments for various psychiatric disorders in the future.
[Display omitted]
•A brief review of the effects of psychobiotics on human mental, neurodegenerative and neurodevelopmental disorders.•Clinical studies of the effects psychobiotics on autism spectrum disorder are summarized.•Psychobiotic supplements show promise as an alternative therapy for human diseases.</abstract><cop>China (Republic : 1949- )</cop><pub>Elsevier Taiwan LLC</pub><pmid>31324280</pmid><doi>10.1016/j.jfda.2019.01.002</doi><tpages>17</tpages><orcidid>https://orcid.org/0000-0002-4390-4742</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1021-9498 |
| ispartof | Journal of food and drug analysis, 2019-07, Vol.27 (3), p.632-648 |
| issn | 1021-9498 2224-6614 2224-6614 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9307042 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection; PubMed Central Open Access |
| subjects | Alzheimer's disease Antidepressants Anxiety Attention deficit hyperactivity disorder Autism Bifidobacterium Brain Brain-derived neurotrophic factor Central nervous system Cognition Disorders Human motion Humans Lactobacillus Mental depression Mental disorders Mental Health Metabolic pathways Movement disorders Nervous system Neurodegenerative diseases Neurodevelopmental disorders Neurodevelopmental Disorders - psychology Neurodevelopmental Disorders - therapy Neurological diseases Parkinson's disease Probiotics Psychiatric disorders Psychobiotics Review Signs and symptoms Studies Yogurt |
| title | Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T00%3A25%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Psychobiotics%20in%20mental%20health,%20neurodegenerative%20and%20neurodevelopmental%20disorders&rft.jtitle=Journal%20of%20food%20and%20drug%20analysis&rft.au=Cheng,%20Li-Hao&rft.date=2019-07-01&rft.volume=27&rft.issue=3&rft.spage=632&rft.epage=648&rft.pages=632-648&rft.issn=1021-9498&rft.eissn=2224-6614&rft_id=info:doi/10.1016/j.jfda.2019.01.002&rft_dat=%3Cproquest_pubme%3E2258096347%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2258096347&rft_id=info:pmid/31324280&rft_els_id=S1021949819300158&rfr_iscdi=true |